JPM

JPMorgan Chase & Co
D

JPM

Arincen43/100B

JPMorgan Chase & Co earnings

JPMorgan Chase & Co reports its Q4 FY2026 results on 14 January 2027, before the market opens. Analysts expect earnings per share of 5.86 USD and revenue of 51.07B USD.

In Q3 FY2026, reported on 13 October 2026, JPMorgan Chase & Co earned 5.75 USD a share against the 5.93 USD analysts expected (-3.0%), on revenue of 50.17B USD against 51.23B USD (-2.1%).

Last EPS surprise
-3.0%
Last revenue surprise
-2.1%
Move after the last report
-0.9%
Average move after earnings
2.2%

EPS and revenue against estimates

Next earnings · Q4 FY2026
EPS estimate
5.86 USD
Revenue estimate
51.07B USD
Last quarter · Q3 FY2026
EPS5.75Missed -3.0%Revenue50.17BMissed -2.1%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q4 FY20265.86——+26.57%51.07B——+11.51%
Q3 FY20265.935.75-3.04%+13.41%51.23B50.17B-2.07%+8.06%
Q2 FY20265.597.70+37.75%+55.24%50.72B57.35B+13.06%+27.77%
Q1 FY20265.475.94+8.59%+17.16%49.18B49.84B+1.33%+9.95%
Q4 FY20254.854.63-4.54%-3.74%46.17B45.80B-0.80%+7.08%
Q3 FY20254.855.07+4.54%+16.02%45.47B46.43B+2.12%+8.85%
Q2 FY20254.484.96+10.71%-18.95%43.81B44.88B+2.44%-12.00%

Beat record

On average, analysts' EPS estimate was 10.6% off the result, either way, and their revenue estimate 4.9%, over the last 12 quarters.

EPS beats
88 / 115
Revenue beats
95 / 114
Average EPS surprise, last 12
+9.3%
Since
April 1997
QuarterReport dateEPS estimateReported EPSSurpriseRevenue estimateReported revenueSurprise
Q3 FY202613 Oct 20265.935.75-3.0%51.23B50.17B-2.1%
Q2 FY202614 Jul 20265.597.70+37.7%50.72B57.35B+13.1%
Q1 FY202614 Apr 20265.475.94+8.6%49.18B49.84B+1.3%
Q4 FY202513 Jan 20264.854.63-4.5%46.17B45.80B-0.8%
Q3 FY202514 Oct 20254.855.07+4.5%45.47B46.43B+2.1%
Q2 FY202515 Jul 20254.484.96+10.7%43.81B44.88B+2.4%
Q1 FY202511 Apr 20254.635.07+9.5%43.99B45.33B+3.0%
Q4 FY202415 Jan 20254.094.81+17.6%41.95B42.77B+2.0%
Q3 FY202411 Oct 20243.994.37+9.5%41.43B42.66B+3.0%
Q2 FY202412 Jul 20245.886.12+4.1%42.23B51.00B+20.8%
Q1 FY202412 Apr 20244.174.63+11.0%41.69B41.91B+0.5%
Q4 FY202312 Jan 20243.733.97+6.4%41.92B38.60B-7.9%

Every earnings report

Report dateQuarterEPS estimateReported EPSSurpriseRevenue estimateReported revenueSurpriseNext-day move
14 Jan 2027UpcomingQ4 FY20265.86——51.07B———
13 Oct 2026Before the market opensQ3 FY20265.935.75-3.0%51.23B50.17B-2.1%-0.9%
14 Jul 2026Before the market opensQ2 FY20265.597.70+37.7%50.72B57.35B+13.1%+2.5%
14 Apr 2026Before the market opensQ1 FY20265.475.94+8.6%49.18B49.84B+1.3%-0.7%
13 Jan 2026Before the market opensQ4 FY20254.854.63-4.5%46.17B45.80B-0.8%-4.2%

The move is the shares' change on the trading day after the report: after a report after the close, the next day's close on the report day's; before the open, the report day's close on the day before's. Surprise is the reported figure against the analysts' average estimate.

See also:Forecast,EPS,Income statement

Common questions about JPMorgan Chase & Co's earnings

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.